Yes, the funding question was answered a little different and glad he said they have a strategy and plan to stop the dilutive financing. I understood the meeting next week is when the funding strategy / plan will be discussed. $12k was less than I expected, but likely misleading and is not the complete cost associated with the study (i.e. CRO expenses are likely much more than that alone).
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.